LINK pdf

[ Pobierz całość w formacie PDF ]

both intra- and extracellular domains of bullous pemphigoid antigen 180. Br J Dermatol. 2001;145:778 783. [PubMed]
122. Leverkus M, Bhol K, Hirako Y, et al. Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin bullous
pemphigoid 180 and bullous pemphigoid 230. Br J Dermatol. 2001;145:998 1004. [PubMed]
123. Rashid KA, G�rcan HM, Ahmed AR. Antigen specificity in subsets of mucous membrane pemphigoid. J Invest
Dermatol. 2006;126:2631 2636. [PubMed]
124. Egan CA, Lazarova Z, Darling TN, Yee C, Yancey KB. Anti-epiligrin cicatricial pemphigoid clinical findings
immunopathogenesis and significant associations. Medicine (Baltimore). 2003;82:177 186. [PubMed]
125. Hanno R, Foster DR, Bean SF. Brunsting-Perry cicatricial pemphigoid associated with bullous pemphigoid. J Am
Acad Dermatol. 1980;3:470 473. [PubMed]
126. Rose C, Schmidt E, Kerstan A, et al. Histopathology of anti-laminin 5 mucous membrane pemphigoid. J Am Acad
Dermatol. 2009;61:433 440. [PubMed]
127. Lazarova Z, Sitaru C, Zillikens D, Yancey KB. Comparative analysis of methods for detection of anti-laminin 5
autoantibodies in patients with anti-epiligrin cicatricial pemphigoid. J Am Acad Dermatol. 2004;51:886 892. [PubMed]
128. Lazarova Z, Yee C, Lazar J, Yancey KB. IgG autoantibodies in patients with anti-epiligrin cicatricial pemphigoid
recognize the G domain of the laminin 5 alpha-subunit. Clin Immunol. 2001;101:100 105. [PubMed]
129. Bhol KC, Dans MJ, Simmons RK, Foster CS, Giancotti FG, Ahmed AR. The autoantibodies to alpha 6 beta 4
integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large
cytoplasmic domain of human beta 4. J Immunol. 2000;165:2824 2829. [PubMed]
130. Bhol KC, Goss L, Kumari S, Colon JE, Ahmed AR. Autoantibodies to human alpha6 integrin in patients with oral
pemphigoid. J Dent Res. 2001;80:1711 1715. [PubMed]
131. Chorzelski TP, Jablonska S. IgA linear dermatosis of childhood (chronic bullous disease of childhood). Br J
Dermatol. 1979;101:535 542. [PubMed]
132. Fortuna G, Salas-Alanis JC, Guidetti E, Marinkovich MP. A critical reappraisal of the current data on drug-induced
linear immuglobulin A bullous dermatosis.A real and separate nosological entity. J Am Acad Dermatol.
2012;66(6):988 94. [PubMed]
20 von 26 25.08.2014 13:05
Molecular Diagnosis in Autoimmune Skin Blistering Conditions http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905716/
133. Zone JJ, Taylor TB, Kadunce DP, Meyer LJ. Identification of the cutaneous basement membrane zone antigen and
isolation of antibody in linear immunoglobulin A bullous dermatosis. J Clin Invest. 1990;85:812 820. [PMC free article]
[PubMed]
134. Marinkovich MP, Taylor TB, Keene DR, Burgeson RE, Zone JJ. LAD-1 the linear IgA bullous dermatosis
autoantigen is a novel 120-kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol.
1996;106:734 738. [PubMed]
135. Pas HH Kloosterhuis GJ, Heeres K, vanderMeer JB, Jonkman MF. Bullous pemphigoid and linear IgA dermatosis
sera recognize a similar 120-kDa keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180. J Invest
Dermatol. 1997;108:423 429. [PubMed]
136. Hirako Y, Usukura J, Uematsu J, Hashimoto T, Kitajima Y, Owaribe K. Cleavage of BP180 a 180-kDa bullous
pemphigoid antigen yields a 120-kDa collagenous extracellular polypeptide. J Biol Chem. 1998;273:9711 9717.
[PubMed]
137. Sch�cke H, Schumann H, Hammami-Hauasli N, Raghunath M, Bruckner-Tuderman L. Two forms of collagen XVII
in keratinocytes.A full-length transmembrane protein and a soluble ectodomain. . J Biol Chem. 1998;273:25937 25943.
[PubMed]
138. Csorba K, Schmidt S, Florea F, et al. Development of an ELISA for sensitive and specific detection of IgA
autoantibodies against BP180 in pemphigoid diseases. Orphanet J Rare Dis. 2011;6:31. [PMC free article] [PubMed]
139. Vodegel RM, deJong MCJM, Pas HH, Jonkman MF. IgA-mediated epidermolysis bullosa acquisita two cases and
review of the literature. J Am Acad Dermatol. 2002;47:919 925. [PubMed]
140. van der, Steen LP, Bakema JE, Sesarman A, et al. Blocking fca receptor i on granulocytes prevents tissue damage
induced by iga autoantibodies. J. Immunol. 2012;189:1594 1601. [PubMed]
141. Schumann H, Baetge J, Tasanen K, et al. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies
in different blistering skin diseases. Am J Pathol. 2000;156:685 695. [PMC free article] [PubMed]
142. Florea F, Torio-Padron N, Hashimoto T, Sitaru C. Non-scarring skin blistering disease and mucosal lesions with IgA
autoantibodies reactive with collagen VII and IgG reactivity with laminin ?2. Br J Dermatol. 2012;167(4):938 41.
[PubMed]
143. Zillikens D, Kawahara Y, Ishiko A, et al. A novel subepidermal blistering disease with autoantibodies to a 200-kDa
antigen of the basement membrane zone. J Invest Dermatol. 1996;106:1333 1338. [PubMed]
144. Dainichi T, Kurono S, Ohyama B, et al. Anti-laminin gamma-1 pemphigoid. Proc Natl Acad Sci USA.
2009;106:2800 2805. [PMC free article] [PubMed]
145. Dainichi T, Koga H, Tsuji T, et al. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid. J Dermatol.
2010;37:231 238. [PubMed]
146. Zillikens D, Ishiko A, Jonkman MF, et al. Autoantibodies in anti-p200 pemphigoid stain skin lacking laminin 5 and
type VII collagen. Br J Dermatol. 2000;143:1043 1049. [PubMed]
147. Liu Y, Shimizu H, Hashimoto T. Immunofluorescence studies using skin sections of recessive dystrophic
epidermolysis bullosa patients indicated that the antigen of anti-p200 pemphigoid is not a fragment of type VII collagen. J
Dermatol Sci. 2003;32:125 129. [PubMed]
148. Koga H, Ishii N, Dainichi T, et al. An attempt to develop mouse model for anti-laminin ?1 pemphigoid. J Dermatol
Sci. 2013;70:108 15. [PubMed]
149. Dilling A, Rose C, Hashimoto T, Zillikens D, Shimanovich I. Anti-p200 pemphigoid a novel autoimmune
subepidermal blistering disease. J Dermatol. 2007;34:1 8. [PubMed]
150. Groth S, Recke A, Vafia K, et al. Development of a simple enzyme-linked immunosorbent assay for the detection of
autoantibodies in anti-p200 pemphigoid. Br J Dermatol. 2011;164:76 82. [PubMed]
151. Woodley DT, Briggaman RA, O'Keefe EJ, Inman AO, Queen LL, Gammon WR. Identification of the skin basement-
membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med. 1984;310:1007 1013. [PubMed]
152. Ishii N, Hamada T, Dainichi T, et al. Epidermolysis bullosa acquisita: what's new. J Dermatol. 2010;37:220 230.
[PubMed]
21 von 26 25.08.2014 13:05
Molecular Diagnosis in Autoimmune Skin Blistering Conditions http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905716/
153. Sitaru C. Experimental models of epidermolysis bullosa acquisita. Exp Dermatol. 2007;16:520 531. [PubMed]
154. Remington J, Chen M, Burnett J, Woodley DT. Autoimmunity to type VII collagen epidermolysis bullosa acquisita.
Curr Dir Autoimmun. 2008;10:195 205. [PubMed]
155. Caux F. Diagnosis and clinical features of epidermolysis bullosa acquisita. Dermatol Clin. 2011;29:485 91.
[PubMed]
156. Luke MC, Darling TN, Hsu R, et al. Mucosal morbidity in patients with epidermolysis bullosa acquisita. Arch
Dermatol. 1999;135:954 959. [PubMed]
157. Hundorfean G, Neurath MF, Sitaru C. Autoimmunity against type VII collagen in inflammatory bowel disease. J Cell
Mol Med. 2010;14:2393 2403. [PMC free article] [PubMed] [ Pobierz całość w formacie PDF ]

Podobne